COVID-19, Influenza, Vaccination Hesitancy
Conditions
Keywords
text message, Short message service (SMS), mHealth
Brief summary
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
Detailed description
The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first season. Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages. Within each practice site, parents of eligible children will be randomized to receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2) COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care). Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.
Interventions
BEHAVIORALText message influenza vaccine reminders
Text message influenza vaccine reminders
BEHAVIORALText message COVID-19 vaccine reminders
Text message COVID-19 vaccine reminders
BEHAVIORALText message influenza and COVID-19 vaccine reminders
Text message influenza and COVID-19 vaccine reminders
Sponsors
Children's Hospital of Philadelphia
American Academy of Pediatrics
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)
Columbia University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
6 Months to 17 Years
Healthy volunteers
No
Inclusion criteria
* Child that: * is 6 months-17 year-old children * due for both a COVID-19 and influenza vaccine * Receives care at study site * Language listed in electronic health record is English or Spanish * Has not opted out of text messages from practice
Exclusion criteria
* Has opted out of text messages from practice * Language listed in electronic health record is not English or Spanish
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Timeliness of influenza vaccination | Up to December 31 each year, up to ~90 days | Days from study start to influenza vaccine up to December 31 each year |
| Timeliness of COVID-19 vaccination | Up to December 31 each year, up to ~90 days | Days from study start to COVID-19 vaccine up to December 31 each year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Participants Who Received Influenza Vaccine by December 31 Each Year | ~3 months | Receipt of influenza vaccine by December 31 each year |
| Percentage of Participants Who Received COVID-19 Vaccine by December 31 Each Year | ~3 months | Receipt of COVID-19 vaccine by December 31 each year |
| Timeliness of influenza vaccination | Up to April 30 each year, up to ~210 days | Days from study start to influenza vaccine up to April 30 each year |
| Percentage of Participants Who Received COVID-19 Vaccine by April 30 Each Year | ~7 months | Receipt of COVID-19 vaccine by April 30 each year |
| Percentage of Participants Who Received Influenza Vaccine by April 30 Each Year | ~7 months | Receipt of influenza vaccine by April 30 each year |
| Timeliness of COVID-19 vaccination | Up to April 30 each year, up to ~210 days | Days from study start to COVID-19 vaccine up to April 30 each year |
Countries
United States
Outcome results
None listed